Old Web
English
Sign In
Acemap
>
authorDetail
>
Roberto D Toto
Roberto D Toto
Dapagliflozin
Medicine
Urology
Diabetes mellitus
Creatinine
3
Papers
616
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL
2021
Kidney International Reports
Glenn M. Chertow
Priya Vart
Niels Jongs
Roberto D Toto
José Luis Górriz
Fan Fan Hou
John J.V. McMurray
Ricardo Correa-Rotter
Peter Rossing
C. D. Sjöström
Bergur V. Stefansson
AM Langkilde
David C. Wheeler
H Lambers Heerspink
Show All
Source
Cite
Save
Citations (1)
POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL
2021
Kidney International Reports
H Lambers Heerspink
Roberto D Toto
Niels Jongs
Priya Vart
Glenn M. Chertow
Fan Fan Hou
John J.V. McMurray
Roberto Pecoits Filho
Ricardo Correa-Rotter
Peter Rossing
C. D. Sjöström
Bergur V. Stefansson
Kausik Umanath
AM Langkilde
David C. Wheeler
Show All
Source
Cite
Save
Citations (0)
Dapagliflozin in Patients with Chronic Kidney Disease
2020
The New England Journal of Medicine
Hiddo J.L. Heerspink
Bergur V. Stefansson
Ricardo Correa-Rotter
Glenn M. Chertow
Tom Greene
Fan Fan Hou
Johannes F.E. Mann
John J.V. McMurray
Magnus Lindberg
Peter Rossing
C. David Sjöström
Roberto D Toto
Am Langkilde
David C. Wheeler
Dapa-Ckd Trial Committees
investigators
Show All
Source
Cite
Save
Citations (615)
1